Qube Research & Technologies LTD Metlife Inc Transaction History

Qube Research & Technologies LTD

$62.3 Billion
Q2 2024

A detailed history of Qube Research & Technologies LTD transactions in Metlife Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 270,167 shares of MET stock, worth $22.2 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

270,167

Previous 177,188 52.47%

Holding current value

$22.2 Million

Previous $13.1 Million 44.41%

% of portfolio

0.03%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$68.55 - $74.22 $6.37 Million - $6.9 Million	92,979 Added 52.47%	270,167 $19 Million
Q1 2024 May 14, 2024	SELL	$65.35 - $74.11 $112 Million - $128 Million	-1,720,819 Reduced 90.66%	177,188 $13.1 Million
Q4 2023 Feb 13, 2024	BUY	$58.29 - $66.9 $111 Million - $127 Million	1,898,007 New	1,898,007 $126 Million
Q2 2023 Aug 14, 2023	SELL	$49.12 - $61.81 $10.4 Million - $13.1 Million	-212,388 Reduced 11.84%	1,581,471 $89.4 Million
Q1 2023 May 15, 2023	BUY	$54.3 - $73.58 $32.8 Million - $44.5 Million	604,448 Added 50.82%	1,793,859 $104 Million
Q4 2022 Feb 14, 2023	BUY	$62.62 - $76.95 $59.4 Million - $73 Million	948,046 Added 392.79%	1,189,411 $86.1 Million
Q3 2022 Nov 14, 2022	BUY	$22.01 - $68.52 $5.31 Million - $16.5 Million	241,365 New	241,365 $14.7 Million
Q3 2021 Nov 12, 2021	SELL	$55.86 - $63.61 $15.7 Million - $17.9 Million	-281,399 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$58.3 - $67.16 $16.4 Million - $18.9 Million	281,399 New	281,399 $16.8 Million
Q1 2021 May 14, 2021	SELL	$46.08 - $61.76 $3.11 Million - $4.16 Million	-67,388 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$36.6 - $48.67 $2.47 Million - $3.28 Million	67,388 New	67,388 $3.16 Million
Q3 2020 Nov 12, 2020	SELL	$35.39 - $40.57 $6.48 Million - $7.43 Million	-183,215 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$27.72 - $43.0 $5.08 Million - $7.88 Million	183,215 New	183,215 $6.69 Million
Q3 2019 Nov 13, 2019	SELL	$43.71 - $50.92 $417,823 - $486,744	-9,559 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$43.93 - $49.67 $1.19 Million - $1.35 Million	-27,150 Reduced 73.96%	9,559 $475,000
Q1 2019 May 15, 2019	BUY	$40.87 - $45.72 $1.02 Million - $1.14 Million	25,030 Added 214.32%	36,709 $1.56 Million
Q4 2018 Feb 14, 2019	BUY	$38.24 - $47.77 $183,131 - $228,770	4,789 Added 69.51%	11,679 $480,000
Q3 2018 Nov 14, 2018	SELL	$43.4 - $48.79 $110,149 - $123,829	-2,538 Reduced 26.92%	6,890 $322,000
Q2 2018 Aug 14, 2018	SELL	$43.6 - $48.46 $197,682 - $219,717	-4,534 Reduced 32.47%	9,428 $411,000
Q1 2018 May 14, 2018	BUY	$44.08 - $54.77 $615,444 - $764,698	13,962 New	13,962 $640,000

Others Institutions Holding MET

# of Institutions

1,472

Shares Held

512M

Call Options Held

6.82M

Put Options Held

6.23M

View Full List

About METLIFE INC

Ticker MET
Exchange NYSE
Sector Financial Services
Industry Insurance—Life
Shares Outstandng 797,614,016
Market Cap $65.6B
Description
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disabilit...

More about MET

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Account

Qube Research & Technologies LTD Metlife Inc Transaction History